$34.53
al cierre: Nov 3 EDT
$33.84
-0.69-2.00%
Pre-comercialización: 4:11 PM EDT
El interés corto en Travere Therapeutics Inc (NASDAQ:TVTX) ha aumentado durante el último período de informe, aumentando en aumento desde 11.24M hasta 11.84M. Esto representa el 13.38% de las acciones disponibles públicamente de la empresa.
El interés en corto en Travere Therapeutics Corp (XNAS:TVTX) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 1.63M acciones negociadas por día, tomaría 7.26 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert  | |||||||||
|---|---|---|---|---|---|---|---|---|---|
TVTX  | Travere Therapeutics, Inc. Com  | 10/15/2025  | 10/24/2025  | 13.38%  | 88,517,698  | 11,840,340  | 1,631,893  | 7.26  | |
TVTX  | Travere Therapeutics, Inc. Com  | 09/30/2025  | 10/09/2025  | 12.70%  | 88,517,698  | 11,241,968  | 2,111,348  | 5.32  | |
TVTX  | Travere Therapeutics, Inc. Com  | 09/15/2025  | 09/24/2025  | 13.92%  | 88,517,698  | 12,319,282  | 3,781,660  | 3.26  | |
TVTX  | Travere Therapeutics, Inc. Com  | 08/29/2025  | 09/10/2025  | 13.65%  | 88,517,698  | 12,081,747  | 1,650,536  | 7.32  | |
TVTX  | Travere Therapeutics, Inc. Com  | 08/15/2025  | 08/26/2025  | 13.68%  | 88,517,698  | 12,107,746  | 1,713,433  | 7.07  | |
TVTX  | Travere Therapeutics, Inc. Com  | 07/31/2025  | 08/11/2025  | 12.00%  | 88,517,698  | 10,624,378  | 1,168,621  | 9.09  | |
TVTX  | Travere Therapeutics, Inc. Com  | 07/15/2025  | 07/24/2025  | 16.02%  | 80,268,582  | 12,859,589  | 1,297,625  | 9.91  | |
TVTX  | Travere Therapeutics, Inc. Com  | 06/30/2025  | 07/10/2025  | 15.57%  | 80,268,582  | 12,499,883  | 1,530,659  | 8.17  | |
TVTX  | Travere Therapeutics, Inc. Com  | 06/13/2025  | 06/25/2025  | 12.87%  | 80,268,582  | 10,329,311  | 1,586,851  | 6.51  | |
TVTX  | Travere Therapeutics, Inc. Com  | 05/30/2025  | 06/10/2025  | 15.58%  | 80,268,582  | 12,502,367  | 2,149,464  | 5.82  | |
TVTX  | Travere Therapeutics, Inc. Com  | 05/15/2025  | 05/27/2025  | 13.00%  | 80,268,582  | 10,434,682  | 1,704,041  | 6.12  | |
TVTX  | Travere Therapeutics, Inc. Com  | 04/30/2025  | 05/09/2025  | 13.25%  | 80,268,582  | 10,637,755  | 1,401,750  | 7.59  | |
TVTX  | Travere Therapeutics, Inc. Com  | 04/15/2025  | 04/25/2025  | 13.76%  | 80,268,582  | 11,046,107  | 2,146,190  | 5.15  | |
TVTX  | Travere Therapeutics, Inc. Com  | 03/31/2025  | 04/09/2025  | 14.40%  | 80,268,582  | 11,556,812  | 1,632,731  | 7.08  | |
TVTX  | Travere Therapeutics, Inc. Com  | 03/14/2025  | 03/25/2025  | 13.95%  | 80,268,582  | 11,194,840  | 1,567,861  | 7.14  | |
TVTX  | Travere Therapeutics, Inc. Com  | 02/28/2025  | 03/11/2025  | 13.64%  | 80,268,582  | 10,948,550  | 1,782,562  | 6.14  | |
TVTX  | Travere Therapeutics, Inc. Com  | 02/14/2025  | 02/26/2025  | 14.08%  | 80,268,582  | 11,301,636  | 2,269,818  | 4.98  | |
TVTX  | Travere Therapeutics, Inc. Com  | 01/31/2025  | 02/11/2025  | 12.16%  | 78,563,059  | 9,555,755  | 1,277,344  | 7.48  | |
TVTX  | Travere Therapeutics, Inc. Com  | 01/15/2025  | 01/27/2025  | 12.19%  | 78,563,059  | 9,577,154  | 1,215,520  | 7.88  | |
TVTX  | Travere Therapeutics, Inc. Com  | 12/31/2024  | 01/10/2025  | 11.10%  | 78,563,059  | 8,719,387  | 1,356,793  | 6.43  | |
TVTX  | Travere Therapeutics, Inc. Com  | 12/13/2024  | 12/24/2024  | 9.43%  | 78,563,059  | 7,405,769  | 1,061,515  | 6.98  | |
TVTX  | Travere Therapeutics, Inc. Com  | 11/29/2024  | 12/10/2024  | 9.64%  | 78,563,059  | 7,574,947  | 1,178,702  | 6.43  | |
TVTX  | Travere Therapeutics, Inc. Com  | 11/15/2024  | 11/26/2024  | 8.87%  | 78,563,059  | 6,971,485  | 1,545,857  | 4.51  | |
TVTX  | Travere Therapeutics, Inc. Com  | 10/31/2024  | 11/11/2024  | 11.75%  | 68,020,241  | 7,991,229  | 1,148,956  | 6.96  | |
TVTX  | Travere Therapeutics, Inc. Com  | 10/15/2024  | 10/24/2024  | 11.92%  | 68,020,241  | 8,107,720  | 2,956,643  | 2.74  | |
TVTX  | Travere Therapeutics, Inc. Com  | 09/30/2024  | 10/09/2024  | 10.24%  | 68,020,241  | 6,962,090  | 2,344,321  | 2.97  | |
TVTX  | Travere Therapeutics, Inc. Com  | 09/13/2024  | 09/24/2024  | 12.73%  | 68,020,241  | 8,657,111  | 2,582,902  | 3.35  | |
TVTX  | Travere Therapeutics, Inc. Com  | 08/30/2024  | 09/11/2024  | 13.60%  | 68,020,241  | 9,253,644  | 693,685  | 13.34  | |
TVTX  | Travere Therapeutics, Inc. Com  | 07/31/2024  | 08/09/2024  | 14.83%  | 68,020,241  | 10,085,762  | 969,300  | 10.41  | |
TVTX  | Travere Therapeutics, Inc. Com  | 07/15/2024  | 07/24/2024  | 14.93%  | 67,657,774  | 10,099,233  | 1,182,373  | 8.54  | |
TVTX  | Travere Therapeutics, Inc. Com  | 06/28/2024  | 07/10/2024  | 15.25%  | 67,657,774  | 10,320,666  | 1,761,121  | 5.86  | |
TVTX  | Travere Therapeutics, Inc. Com  | 06/14/2024  | 06/26/2024  | 19.83%  | 67,657,774  | 13,414,704  | 837,545  | 16.02  | |
TVTX  | Travere Therapeutics, Inc. Com  | 05/31/2024  | 06/11/2024  | 19.90%  | 67,657,774  | 13,466,678  | 1,040,843  | 12.94  | |
TVTX  | Travere Therapeutics, Inc. Com  | 05/15/2024  | 05/24/2024  | 19.87%  | 67,657,774  | 13,441,029  | 1,209,992  | 11.11  | |
TVTX  | Travere Therapeutics, Inc. Com  | 04/30/2024  | 05/09/2024  | 18.94%  | 67,657,774  | 12,811,095  | 1,373,404  | 9.33  | |
TVTX  | Travere Therapeutics, Inc. Com  | 04/15/2024  | 04/24/2024  | 17.45%  | 67,637,585  | 11,802,198  | 1,352,724  | 8.72  | |
TVTX  | Travere Therapeutics, Inc. Com  | 03/28/2024  | 04/09/2024  | 15.67%  | 67,637,585  | 10,601,943  | 988,081  | 10.73  | |
TVTX  | Travere Therapeutics, Inc. Com  | 03/15/2024  | 03/26/2024  | 13.30%  | 75,730,599  | 10,071,652  | 1,191,648  | 8.45  | |
TVTX  | Travere Therapeutics, Inc. Com  | 02/29/2024  | 03/11/2024  | 13.55%  | 75,730,599  | 10,260,892  | 1,290,410  | 7.95  | |
TVTX  | Travere Therapeutics, Inc. Com  | 01/31/2024  | 02/09/2024  | 13.28%  | 74,777,945  | 9,930,252  | 1,313,136  | 7.56  | |
TVTX  | Travere Therapeutics, Inc. Com  | 01/12/2024  | 01/24/2024  | 12.98%  | 74,777,945  | 9,706,853  | 1,596,172  | 6.08  | |
TVTX  | Travere Therapeutics, Inc. Com  | 12/29/2023  | 01/10/2024  | 13.27%  | 74,777,945  | 9,919,315  | 1,209,394  | 8.2  | |
TVTX  | Travere Therapeutics, Inc. Com  | 12/15/2023  | 12/27/2023  | 12.90%  | 74,777,945  | 9,644,767  | 2,292,358  | 4.21  | |
TVTX  | Travere Therapeutics, Inc. Com  | 11/30/2023  | 12/11/2023  | 13.31%  | 74,777,945  | 9,953,359  | 1,311,154  | 7.59  | |
TVTX  | Travere Therapeutics, Inc. Com  | 11/15/2023  | 11/27/2023  | 14.25%  | 74,777,945  | 10,656,025  | 2,183,179  | 4.88  | |
TVTX  | Travere Therapeutics, Inc. Com  | 10/31/2023  | 11/09/2023  | 11.78%  | 74,777,945  | 8,805,307  | 1,520,475  | 5.79  | 
En busca de los valores más cortos?